The ambiguity of the JW modifier — first, the announcement on June 9 by the Centers for Medicare & Medicaid Services of the JW delay until January 2017 and then, as recently as August 26, an update from CMS on what items for which the JW modifier will not be required such as reporting on packaged OPPS drugs — continues to thwart effective planning by hospital pharmacy professionals.
By attending this timely webcast, hospital pharmacy professionals will become aware of the potential impact that the JW modifier can have on their organization and also know how critical documentation and medical necessity are to a successful transition.
Why This Webcast is Important
Pharmacies will have to figure out which department will be responsible for reporting the wastage and also be sure that the patient's medical record includes sufficient documentation to support the billed unit of service for both the administered dose and the discarded waste. Even though implementation of the JW modifier only affects waste from single-dose drugs, it can be a daunting task to ensure that your pharmacy information system is correctly reporting the waste from just these drugs.
Let's face it, pharmacy operations are extremely difficult to manage. But this timely webcast will help you and your staff gain a better understanding of the elusive JW modifier.
From this essential webcast series, you will gain the knowledge to:
- Understand the history of the JW modifier, what it is, and how it can affect an organization;
- Identify the information needed to combat issues associated with JW Modifier;
- Understand how your information systems work to produce claims;
- Interpret new documentation standards to help prevent denials and avoid thousands of dollars in Medicare paybacks; and,
- Understand the "value" associated with providing medical necessity